Brief: NRX Pharmaceuticals Announces Potent Antibacterial Activity Of Nrx-101 Against Common, Antibiotic Resistant Urinary Pathogens
06/09/2023 18:28
Sept 6 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES POTENT ANTIBACTERIAL
ACTIVITY OF
NRX-101 AGAINST COMMON, ANTIBIOTIC RESISTANT URINARY PATHOGENS
Source text for Eikon: ID:nPn1mlP8ca
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview